Forward Look Watch Your Mouth Dental screening before treatment could stave off dental emergencies. by Nancy Averett Q&A The Lost Poetry of Patient Stories Medical histories capture a vital snapshot of a patient’s health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative. by Marci A. Landsmann Keeping CLL in Check With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease. by Kendall K. Morgan Get Involved Filling a Void A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers. by Elizabeth Rosto Sitko Despite Generic Imatinib, Cost of Treating CML Remains High The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds. by Anna Azvolinsky When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Finding More Targets for CAR-T Cells CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy. by Kendall K. Morgan FROM THE EDITOR-IN-CHIEF Clonal Hematopoiesis: You Are Not the Same Person You Used to Be DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop. by William G. Nelson, MD, PhD FORWARD LOOK Pediatric Leukemia Treatments Are Not Just for Kids Study supports using these regimens for teens and young adults. by Bradley Jones next Cancer Talk Survival Statistics 101 Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean. by Ashley P. Taylor Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus. by Marcus A. Banks Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua More Posts